125 related articles for article (PubMed ID: 24914721)
21. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
22. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation.
Yao Y; Xie Y; Hong C; Li G; Shen H; Ji G
Carbohydr Polym; 2014 Sep; 110():329-37. PubMed ID: 24906763
[TBL] [Abstract][Full Text] [Related]
23. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
24. Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement.
Huang Y; Zu Y; Zhao X; Wu M; Feng Z; Deng Y; Zu C; Wang L
Int J Pharm; 2016 Sep; 511(2):921-30. PubMed ID: 27515291
[TBL] [Abstract][Full Text] [Related]
25. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
[TBL] [Abstract][Full Text] [Related]
26. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin.
Lu Y; Yang L; Zhang W; Xie S; Zhao F; Peng X; Qin Z; Zeng D; Zeng Z
Drug Deliv; 2022 Dec; 29(1):2824-2830. PubMed ID: 36062487
[TBL] [Abstract][Full Text] [Related]
29. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
Garnero C; Zoppi A; Genovese D; Longhi M
Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
[TBL] [Abstract][Full Text] [Related]
30. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
31. Enhanced bioavailability of soy isoflavones by complexation with beta-cyclodextrin in rats.
Lee SH; Kim YH; Yu HJ; Cho NS; Kim TH; Kim DC; Chung CB; Hwang YI; Kim KH
Biosci Biotechnol Biochem; 2007 Dec; 71(12):2927-33. PubMed ID: 18071265
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
[TBL] [Abstract][Full Text] [Related]
33. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
34. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
35. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
Garnero C; Longhi M
J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
[TBL] [Abstract][Full Text] [Related]
36. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
37. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
38. HPLC method with fluorescence detection for the determination of ligustilide in rat plasma and its pharmacokinetics.
Zhang XY; Qiao H; Shi YB
Pharm Biol; 2014 Jan; 52(1):21-30. PubMed ID: 24044763
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of 16-dehydropregnenolone hydroxypropyl-β-cyclodextrin inclusion complex following peroral administration.
Sun Y; Jia L; Zhou H; Mao M; Wang X; Wei L; Sun L
Pharm Dev Technol; 2017 Mar; 22(2):218-228. PubMed ID: 27269370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
